PRISM Program for Metastatic Breast Cancer Support

Inclusion Criteria: * Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information. * Participants are willing and able to comply with study procedures based on the judgement of the investigator. * Male and female patients of age \>18 years. * Pathologic diagnosis of metastatic breast cancer within 182 days prior to enrollment date. * Able to answer surveys and participate in counseling sessions in English (the patient's first language is not required to be English). * Indicate intent to receive ongoing cancer care at the enrolling institution. Exclusion Criteria: Individuals meeting any of the following exclusion criteria will be excluded from study participation. * Patient unwilling or unable to complete surveys via one of the following methods: (a) paper survey completed in clinic or mailed directly to patient's home address, including a pre-addressed, pre-stamped return envelope in the mailed survey packet, or (b) electronic survey links sent via emails or text link on a mobile device, tablet, laptop, or desktop computer. * Patient unwilling or unable to provide verbal or signed consent to participate. * Participant cannot read English. * Patient has permanently discontinued cancer-directed therapy or does not intend to receive any cancer-directed therapy, is receiving home or residential hospice care, is hospitalized, or is described as likely to die within 90 days or actively dying in last provider documentation, at the time of enrollment.